| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |